WELCOME TO THE PLASTICISE PROJECT !
PLASTICISE is a research consortium bringing together leading scientists, clinicians, small biotech and large pharmaceutical companies from 8 different European countries. The researchers are working together to identify new ways of promoting plasticity in the adult brain following a damage.
Brain diseases including Stroke, Traumatic Brain Injury, Spinal Cord injury and Alzheimer’s disease represent the majority of long-term disabled people in Europe. These diseases all cause damage to the circuitry of the nervous system (brain and spinal cord), with loss of connections, axons and neurons. The loss can be gradual, as in Alzheimer’s disease, rapid as in stroke, or intermediate as in the delayed neuronal loss after stroke. The concept that unites them is the belief that treatments that enhance plasticity will become one of key medications that will improve neurological function in the damaged human nervous system. The purpose of the project is to bring this moment closer.
 |
Vision |  |
Stroke |  |
Animal |
 |
Promoting plasticity |
 |
Brain function recovery |  |
Spinal cord |
 |
Alzheimer's |
The focus of the PLASTICISE project is the development of new treatments to promote plasticity and of methods to measure and visualise their effects, focussing on Alzheimer’s disease, stroke and damaged visual system. The outcome will be the better understanding of the disease conditions and mechanisms underlying the loss ofplasticity in the injured tissue and upon such a base for developing new and effective treatment strategies in Alzheimer’s disease and stroke.
The PLASTICISE project is funded by the 7th Framework Programme of the European Commission, Contract No. HEALTH-F2-2009-223524
| Latest News | Upcoming Events | |
|
|
|
 |
 'Last update - April 2012' |